Early Versus Late Administration of P2Y12 Inhibitors in Non-ST Segment Elevation Myocardial Infarction and Delayed Cardiac Catheterization

被引:0
|
作者
Lycouras, Maggie M. [1 ]
Clark, Collin M. [1 ,2 ]
Mills, Kevin [1 ]
Gupta, Aman [3 ]
Chilbert, Maya R. [1 ,2 ]
机构
[1] Buffalo Gen Med Ctr, Pharm Dept, Buffalo, NY USA
[2] Univ Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[3] Buffalo Gen Med Ctr, Cardiol Dept, Buffalo, NY USA
关键词
P2Y(12) inhibitors; NSTEMI; GP IIb; IIIa inhibitor; bleeding; troponin; METAANALYSIS; ANGIOGRAPHY; ANTAGONISTS; DEFINITION; RISK;
D O I
10.1097/FJC.0000000000001302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regardless of early invasive or ischemia-guided approaches to non-ST segment elevation myocardial infarction (NSTEMI) management, P2Y(12) inhibitors remain the backbone in therapy. The ideal timing of administration remains unclear. The purpose of this study was to determine the safety and effectiveness of early versus late administration of P2Y(12) inhibitors in patients presenting with an NSTEMI who go to the catheterization laboratory beyond 24 hours from presentation. We performed a single center, retrospective cohort study. Patients were classified into groups depending on whether they received early versus late administration of a P2Y(12) inhibitor. The primary outcome was the rate of major and clinically relevant, nonmajor bleeding (CRNMB). Secondary outcomes included troponin peak and length of stay after cardiac catheterization. Of the 121 patients included, 53 patients were in the early and 68 patients were in the late group. The number of bleeding events were similar between both groups (P = 1.00). There were 3 (5.7%) major bleeding events in the early group and 5 (7.4%) bleeding events in the late group. There were 5 (9.4%) CRNMB events in the early group and 6 (8.8%) CRNMB events in the late group. There was a significant difference in troponin peak, 4.56 ng/mL in the early group and 1.77 ng/mL in the late group (P = 0.02). The rate of bleeding did not differ between patients who received early or late administration of P2Y(12) inhibitors for NSTEMI management who undergo delayed cardiac catheterization.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 50 条
  • [31] The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis
    Bellemain-Appaix, A.
    Begue, C.
    Bhatt, D. L.
    Ducci, K.
    Harrington, R. A.
    Roe, M. T.
    Wiviott, S. D.
    Cucherat, M.
    Silvain, J.
    Collet, J. P.
    Bernasconi, F.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1263 - 1264
  • [32] The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis
    Bellemain-Appaix, Anne
    Begue, Celine
    Bhatt, Deepak L.
    Ducci, Kenneth
    Harrington, Robert A.
    Roe, Matthew
    Wiviott, Stephen D.
    Cucherat, Michel
    Silvain, Johanne
    Collet, Jean-Philippe
    Bernasconi, Francois
    Montalescot, Gilles
    EUROINTERVENTION, 2018, 14 (01) : 78 - 85
  • [33] Medical Versus Invasive Management of Non-ST Segment Elevation Myocardial Infarction in Diabetes Mellitus
    Luizzi, Alexander B.
    Le, Austin V.
    Gill, Gauravpal S.
    Walters, Ryan W.
    Del Core, Michael
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 44 : 32 - 36
  • [34] Bupivacaine induced cardiac toxicity mimicking an acute non-ST segment elevation myocardial infarction
    Ryu, Ho Yoel
    Kim, Jang-Young
    Lim, Hyun Kyo
    Yoon, Junghan
    Yoo, Byung-Su
    Choe, Kyung-Hoon
    Lee, Seung-Hwan
    YONSEI MEDICAL JOURNAL, 2007, 48 (02) : 331 - 336
  • [35] Effect of early bisoprolol administration on ventricular arrhythmia and cardiac death in patients with non-ST elevation myocardial infarction
    Maclean, Edd
    Zheng, Sean
    Nabeebaccus, Adam
    O'Gallagher, Kevin
    Stewart, Adrian
    Webb, Ian
    HEART ASIA, 2015, 7 (02) : 46 - 51
  • [36] NEWER P2Y12 INHIBITORS VERSUS CLOPIDOGREL IN ACUTE MYOCARDIAL INFARCTION WITH CARDIAC ARREST OR CARDIOGENIC SHOCK
    Patlolla, Sri Harsha
    Kandlakunta, Harika
    Kuchkuntla, Aravind R.
    Vallabhajosyula, Saraschandra
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1080 - 1080
  • [37] Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial
    Tavenier, Anne H.
    Claassens, Daniel M. F.
    Hermanides, Renicus S.
    Vos, Gerrit J. A.
    Bergmeijer, Thomas O.
    Kelder, Johannes C.
    Deneer, Vera H. M.
    Hof, Arnoud W. J. van 't
    Ten Berg, Jurrien M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 (03) : 676 - 685
  • [38] Cardiac Catheterization in Kidney Transplant Patients Presenting with Non-ST Segment Elevation Myocardial Infarction: A Five-year Nationwide Analysis
    Al Akeel, Mohannad
    Eldawud, Daoud
    Jha, Mayank
    Harikrishna, Arya
    Jain, Hritvik
    Abdulfattah, Ammar
    Alamro, Yazan
    Patel, Jeetendra
    CIRCULATION, 2024, 150
  • [39] Underutilization of left heart catheterization in kidney transplant patients presenting with non-ST segment elevation myocardial infarction
    Mustafa, Ahmad
    Asmar, Samer
    Wei, Chapman
    Afif, John
    Khan, Shahkar
    Rizvi, Taqi
    Grovu, Radu
    Weinberg, Mitchell
    El-Sayegh, Suzanne
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2023, 30
  • [40] Early versus late delayed percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction
    Jiachun Lang
    Chen Wang
    Jingxia Zhang
    Yuecheng Hu
    Lin Wang
    Yin Liu
    Rongdi Xu
    Jikun Wu
    Wei Qi
    Chunwei Liu
    Wenyu Li
    Tingting Li
    Dongxia Jin
    Ao Wei
    Le Wang
    Hongliang Cong
    Aging Clinical and Experimental Research, 2023, 35 : 1317 - 1324